ArticleFrontiers in immunology2025

Low-dose glucocorticoid improves progression-free survival of children with B cell acute lymphoblastic leukaemia following chimeric antigen receptor T-cell therapy.

Hui Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.